Douglas G. Walker

20.4k citations

173 papers · 13.7k indexed · 3 hit papers · h-index 64

Impact in

Neurology top 0.05%
- Neuroinflammation and Neurodegeneration Mechanisms
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Neurological Disease Mechanisms and Treatments
Biological Psychiatry top 0.2%
- Tryptophan and brain disorders

Papers in

Neurology 66
- Neuroinflammation and Neurodegeneration Mechanisms 54
- Parkinson's Disease Mechanisms and Treatments 29
- Neurological Disease Mechanisms and Treatments 14
- Neurological disorders and treatments 13
Physiology 106
- Alzheimer's disease research and treatments 102

Co-authors: Lih‐Fen Lue Patrick L. McGeer Thomas G. Beach Lucia I. Sue Marwan N. Sabbagh Charles H. Adler Edith G. McGeer Ikuo Tooyama
Journals: Brain Research (16 papers)Neurobiology of Aging (8 papers)Acta Neuropathologica (7 papers)Movement Disorders (6 papers)Journal of Alzheimer s Disease (6 papers)
Partner nations: United States Canada Japan

In The Last Decade

Douglas G. Walker

172 papers receiving 13.4k citations

Hit Papers

align trajectories log scale

Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders 2010 · 690 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2010 Acta Neuropathologica
2009 Acta Neuropathologica
1993 Glia

Peers

Countries citing papers authored by Douglas G. Walker

Since Specialization

Citations

This map shows the geographic impact of Douglas G. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas G. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas G. Walker more than expected).

Fields of papers citing papers by Douglas G. Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas G. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas G. Walker. The network helps show where Douglas G. Walker may publish in the future.

Co-authors

The 25 scholars most cited alongside Douglas G. Walker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Douglas G. Walker Line = papers co-authored together Douglas G. Walker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Localization of Thioredoxin-Interacting Protein in Aging and Alzheimer’s Disease Brains SHILAP Revista de lepidopterología ·王维, Takaki Aihara, Yerli Nabely Ortiz, Ikuo Tooyama, Douglas G. Walker	2022	1
2	Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts Frontiers in Aging Neuroscience ·Lih‐Fen Lue, Marwan N. Sabbagh, Ming‐Jang Chiu, S. A. Conning, Pelin Yiğit, Christopher T. Schmitz, André Guerra, Christine M. Belden, Ta‐Fu Chen, A Ferreyra Romualdo, Shieh‐Yueh Yang, Douglas G. Walker, Kewei Chen, Eric M. Reiman	2017	86
3	Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer’s disease brains and human microglia Neuroscience ·Douglas G. Walker, Asaad Ali Mohammed Habbash, Lih‐Fen Lue	2014	45
4	Increased Alzheimer’s Disease Neuropathology is Associated with Type 2 Diabetes and ApoE ε4 Carrier Status Current Alzheimer Research ·Michael Malek‐Ahmadi, Thomas G. Beach, Ciara Farmer, Lucia I. Sue, Christine M. Belden, Kathryn Davis, Douglas G. Walker, Lih‐Fen Lue, Abdu Adem, Marwan N. Sabbagh	2013	50
5	Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging Journal of Parkinson s Disease ·Brittany N. Dugger, Geidy E. Serrano, Lucia I. Sue, Douglas G. Walker, Charles H. Adler, Holly A. Shill, Marwan N. Sabbagh, John N. Caviness, José A. Hidalgo, Tiffany Rosenzweig, جواد خلعتبری, Kanit Soongprasit, Kristina Pettersson Granqvist, Thomas G. Beach	2012	26
6	Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease Acta Neuropathologica ·Pamela E. Potter, Igor Grčman, Stephanie B. Jilcott Pitts, Lucia I. Sue, Marwan N. Sabbagh, Douglas G. Walker, Thomas G. Beach	2011	69
7	Parkinson's disease, cortical dysfunction, and alpha‐synuclein Movement Disorders ·John N. Caviness, Lih‐Fen Lue, Thomas G. Beach, Joseph G. Hentz, Charles H. Adler, Lucia I. Sue, Ramin Sadeghi, Erika Driver‐Dunckley, Virgilio Gerald H. Evidente, Marwan N. Sabbagh, Holly A. Shill, Douglas G. Walker	2011	16
8	Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging PLoS ONE ·Chera L. Maarouf, Ian D. Daugs, Tyler A. Kokjohn, Douglas G. Walker, Jesse M. Hunter, G. Sabatino, Randy Woltjer, Jeffrey Kaye, Wenchang Situ, Marwan N. Sabbagh, Thomas G. Beach, Alex E. Roher	2011	54
9	Parkinson's Disease Dementia and Potential Therapeutic Strategies CNS Neuroscience & Therapeutics ·John N. Caviness, Lih-Fen Lue, Charles H. Adler, Douglas G. Walker	2010	38
10	Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: A potential mechanism leading to chronic inflammation Experimental Neurology ·Douglas G. Walker, Jessica Dalsing-Hernandez, Cabezas Gutierrez, Lih‐Fen Lue	2008	206
11	Reduced striatal tyrosine hydroxylase in incidental Lewy body disease Acta Neuropathologica ·Thomas G. Beach, Charles H. Adler, Lucia I. Sue, Фиранчук Александр Сергеевич, Shakul Kumar, Jessica Dalsing-Hernandez, Lih Fen Lue, John N. Caviness, Donald J. Connor, Marwan N. Sabbagh, Douglas G. Walker	2007	96
12	Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues Experimental Cell Research ·Ashani T. Weeraratna, Audrey N. Kalehua, J. Ovens, Vasyl Dovhanych, Syafiul Abrar, Michael S. Wade, Ana Lustig, Kevin G. Becker, William W. Wood, Douglas G. Walker, Thomas G. Beach, Dennis D. Taub	2006	85
13	Gene expression correlates of neurofibrillary tangles in Alzheimer's disease Neurobiology of Aging ·Travis Dunckley, Thomas G. Beach, Keri E. Ramsey, Andrew Grover, Diego Mastroeni, Douglas G. Walker, Bonnie LaFleur, Keith D. Coon, Kevin M. Brown, Richard J. Caselli, Walter A. Kukull, Roger Higdon, Daniel W. McKeel, John C. Morris, Christine Hulette, Donald E. Schmechel, Eric M. Reiman, Joseph Rogers, Dietrich A. Stephan	2005	142
14	Hippocampal Sclerosis Dementia with Tauopathy Brain Pathology ·Thomas G. Beach, Lucia I. Sue, Sarah Scott, Y. Cho, Amanda Newell, Douglas G. Walker, Matthew Baker, T.H.K. Barron, Shu‐Hui Yen, Michael Hutton, Richard J. Caselli, Charles H. Adler, Donald J. Connor, Marwan N. Sabbagh	2003	68
15	Elucidating Molecular Mechanisms of Alzheimer’s Disease in Microglial Cultures PubMed ·Jack T. Rogers, Lih‐Fen Lue, Douglas G. Walker, S D Yan, D Stern, Ron Strohmeyer, Carl J. Kovelowski	2002	15
16	Reduction of cerebrospinal fluid amyloid β after systemic administration of M1 muscarinic agonists Brain Research ·Thomas G. Beach, Douglas G. Walker, Pamela E. Potter, Lucia I. Sue, Abraham Fisher	2001	55
17	Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia Neurobiology of Aging ·Douglas G. Walker	2001	133
18	Expression of presenilin-1 and -2 mRNAs in rat and Alzheimer's disease brains Brain Research ·Kenji Takami, Kazuhiro Terai, Akinori Matsuo, Douglas G. Walker, Patrick L. McGeer	1997	54
19	Expression and regulation of glial-cell-line-derived neurotrophic factor (GDNF) mRNA in human astrocytes in vitro Cell and Tissue Research ·Giuseppe Moretto, Douglas G. Walker, Paola Lanteri, Federica Taioli, Stefano Zaffagnini, Ren Xu, Nicolo’ Rizzuto	1996	33
20	In Situ Hybridization Analysis for Herpes Simplex Virus Nucleic Acids in Alzheimer Disease Alzheimer Disease & Associated Disorders ·Douglas G. Walker, John R. OʼKusky, Patrick L. McGeer	1989	21

About Douglas G. Walker

Douglas G. Walker is a scholar working on Neurology, Physiology, Biological Psychiatry, Neurology and Clinical Biochemistry, having authored 173 papers that have together received 13.7k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (102 papers), Neuroinflammation and Neurodegeneration Mechanisms (54 papers), Parkinson's Disease Mechanisms and Treatments (29 papers), Neurological Disease Mechanisms and Treatments (14 papers), Neurological disorders and treatments (13 papers), S100 Proteins and Annexins (12 papers), Dementia and Cognitive Impairment Research (12 papers) and Tryptophan and brain disorders (10 papers). The work is most often cited by research in Neurology (5.1k citations), Biological Psychiatry (977 citations), Physiology (6.4k citations), Neurology (2.9k citations) and Developmental Neuroscience (541 citations). Douglas G. Walker has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Lih‐Fen Lue, Patrick L. McGeer, Thomas G. Beach, Lucia I. Sue, Marwan N. Sabbagh, Charles H. Adler, Edith G. McGeer, Ikuo Tooyama, Toshio Kawamata and John N. Caviness. Their work appears in journals such as Brain Research, Neurobiology of Aging, Acta Neuropathologica, Movement Disorders and Journal of Alzheimer s Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact